Prognostic indicators in head and neck oncology including the New 7th edition of the AJCC staging system

Head and Neck Pathology

Volumn 4, Issue 1, 2010, Pages 53-61

  Brandwein Gensler, Margaret ^a   Smith, Richard V ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOOK; CANCER STAGING; CLASSIFICATION; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MEDICAL SOCIETY; METHODOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STANDARD; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MANUALS AS TOPIC; NEOPLASM STAGING; PROGNOSIS; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 77952884232     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-010-0161-y     Document Type: Article

References (64)

1. American joint committee on cancer-cancer staging manual. 7th ed. Springer; 2010.
2. Yuen AP, Chow TL, Cheung WY, et al. Prospective randomized study of selective neck dissection versus observation for no neck of early tongue carcinoma. Head Neck. 2009; 31: 765-72.
3. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in squamous carcinoma of tongue a prospective randomized trial. Am J Surg. 1989; 158: 309-13.
4. Fukano H, Matsuura H, Hasegawa Y, Nakamura S. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck. 1997; 19: 205-10.
5. Sporano A, Weinstein G, Challian A, et al. Mulitvariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004; 131: 472-6.
6. An S, Jung EJ, Lee M, et al. Factors related to regional recurrence in early stage squamous cell carcinoma of the oral tongue. Clin Exp Otorhinolaryngol. 2008; 1: 166-70.
7. Mohit-Tabatabai MA, Sobel HJ, Rush BF, Mashberg A. Relation of thickness of floor of mouth stage I and II cancers to regional metastasis. Am J Surg. 1986; 152: 351-3.
8. Suzuki M, Suzuki T, Asai M, et al. Clinicopathologic factors related to cervical lymph node metastasis in a patient with carcinoma of the oral floor. Acta Oto Laryngol. 2007; 127: 129-35.
9. Wallwork BD, Anderson SR, Coman WB. Squamous cell carcinoma of the floor of the mouth: tumor thickness and the rate of cervical metastasis. ANZ J Surg. 2007; 77: 761-4.
10. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for oral tongue cancer. Laryngoscope. 2002; 112: 616-25.
11. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinoma. Scan J Dent Res. 1987; 95: 229-49.
12. Bryne M, Koppang HS, Lilleng R, et al. New malignancy grading is a better prognostic indicator than broders' grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989; 18: 432-7.
13. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992; 166: 375-81.
14. Bryne M, Jenssen N, Boysen M. Histologic grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virch Archiv. 1995; 427: 277-81.
15. Bundgaard T, Rossen K, Henriksen SD, et al. Histologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head Neck. 2002; 24: 656-60.
16. Jakobsson PA, Eneroth CM, Killander D, et al. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol. 1973; 12: 1-8.
17. Odell EW, Jani P, Sherriff M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer. 1994; 74: 789-94.
18. Po WYA, Lam KY, Lam LK, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma. A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck. 2002; 24: 513-20.
19. Sawair FA, Irwin CR, Gordon DJ, et al. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med. 2003; 32: 1-9.
20. Warburton G, Nikitakis NG, Roberson P, et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg. 2007; 65: 475-84.
21. Fagan JJ, Collins B, Barnes L, et al. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998; 124: 637-40.
22. Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97: 423-31.
23. Sethi S, Lu M, Kapke A, et al. Patient and tumor factors at diagnosis in a multi-ethnic primary head and neck squamous cell carcinoma cohort. J Surg Oncol. 2009; 99: 104-8.
24. McMahon J, O'Brien CJO, Pathak I, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral and Maxillofac Surg. 2003; 41: 224-31.
25. Brandwein-Gensler M, Lewis C, Lee B, et al. Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005; 20: 167-78.
26. Brandwein-Gensler M, Smith RV, Wang B, et al. Validation and reproducibility of the histological risk model in a new patient cohort with head and neck squamous cell carcinoma. Am J Surg Path. Accepted for publication.
27. Byers RM, Bland KI, Borlase B, Luna M. The prognostic and therapeutic value of frozen section determination in the surgical treatment of squamous cell carcinoma of the head and neck. Am J Surg. 1978; 136: 525-8.
28. Chen TY, Edmrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Rad Oncol Biol Phys. 1987; 13: 833-7.
29. Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg. 1990; 160: 410-4.
30. Garzino-Demo P, Dell'Acqua A, Dalmasso P, et al. Clinicopathologic parameters and outcome of 245 patients operated for oral squamous cell carcinoma. J Cranio Maxillofac Surg. 2006; 34: 344-50.
31. El-Husseiny G, Kandil A, Jamshed A, et al. Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Brit J Oral Maxillofac Surg. 2000; 38: 193-9.
32. Amaral TMP, Freire ARS, Carvalho AL, et al. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of mouth. Oral Oncol. 2004; 40: 780-6.
33. Weijers M, Snow GB, Bezemer DP, et al. The status of the deep surgical margins in tongue and floor of mouth squamous cell carcinoma and risk of local recurrence: an analysis of 68 patients. Int J Oral Maxillofac Surg. 2004; 33: 146-9.
34. Ryerson AB, Peters ES, Coughlin SS, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008; 113: 2901-9.
35. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control. 2000; 11: 489-95.
36. Chaturvedi AK, ENgels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-9.
37. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between HPV and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-20.
38. Mellin H, Friesland S, Lewensohn R, et al. HPV DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000; 89: 300-4.
39. Schwartz SR, Yueh B, McDougall JK, et al. HPV infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg. 2001; 125: 1-9.
40. Mork J, Lie AK, Glattre E, et al. HPV infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001; 344: 1125-31.
41. Ringstrom E, Peters E, Hasegawa M, et al. HPV type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002; 10: 3187-92.
42. Dahlstrom KR, Adler-Storthz K, et al. HPV type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003; 9: 2620-6.
43. El-Mofty SK, Lu DW. Prevalence of HPV type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003; 11: 1463-70.
44. Herrero R, Castellsague X, Pawlita M, et al. HPV and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Inst. 2003; 95: 1772-83.
45. Begum S, Cao D, Gillison M, et al. Tissue distribution of HPV 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2005; 11: 5694-9.
46. Hansson BG, Rosenquist K, Antonsson A, et al. Strong association between infection with HPV and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 2005; 125: 1337-44.
47. Ibieta BR, Lizano M, Fras-Mendivil M, et al. HPV in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 99: 311-5.
48. Koppikar P, de Villiers EM, Mulherkar R. Identification of HPV in tumors of the oral cavity in an Indian community. Int J Cancer. 2005; 113: 946-50.
49. Kreimer AR, Clifford GM, Snijders PJ, et al. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer. 2005; 115: 329-32.
50. Tachezy R, Klozar J, Salakova M, et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech republic. Oral Dis. 2005; 11: 181-5.
51. El-Mofty SK, Patil S. HPV-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 339-45.
52. Licitra L, Perrone F, Bossi P, et al. High-risk HPV affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006; 24: 5630-6.
53. Nemes JA, Deli L, Nemes Z, Marton IJ. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of HPV genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102: 344-52.
54. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of HPV-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006; 24: 736-47.
55. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of HPV and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944-56.
56. Furniss CS, McClean MD, Smith JF, et al. HPV 16 and head and neck squamous cell carcinoma. Int J Cancer. 2007; 120: 2386-92.
57. Pintos J, Black MJ, Sadeghi N, et al. HPV infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol. 2008; 44: 242-50.
58. Smith EM, Ritchie JM, Pawlita M, et al. HPV seropositivity and risks of head and neck cancer. Int J Cancer. 2007; 120: 825-32.
59. Schlecht NF, Burk RD, Adrien L, et al. Gene expression profiles in HPV-infected head and neck cancer. J Pathol. 2007; 213: 283-93.
60. Fischer CA, Zlobec I, Green E, et al. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer; 2009 Aug 20 [Epub ahead of print].
61. Wittekindt C, Gültekin E, Weissenborn SJ, et al. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv Otorhinolaryngol. 2005; 62: 72-80.
62. Kim SH, Koo BS, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer. 2007; 120: 1418-25.
63. Charfi L, Jouffroy T, de Cremoux P, et al. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett. 2008; 260: 72-8.
64. Kuo KT, Hsiao CH, Lin CH, et al. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol. 2008; 21: 376-86.